Global fund takes stake in Recce as synthetic antibiotic developer raises $11m Posted on October 6, 2023September 25, 2024 by recce_com Global fund takes stake in Recce as synthetic antibiotic developer raises $11m
Recce Pharmaceuticals raises further funds to progress trials from entitlement shortfall Posted on October 6, 2023September 25, 2024 by recce_com Recce Pharmaceuticals raises further funds to progress trials from entitlement shortfall
Recce Pharmaceuticals advances anti-infective development and clinical trials in FY23 Posted on October 2, 2023September 25, 2024 by recce_com Recce Pharmaceuticals advances anti-infective development and clinical trials in FY23
Recce Pharmaceuticals (ASX:RCE) completes cohort dosing in UTI rapid infusion trial Posted on September 22, 2023September 25, 2024 by recce_com Recce Pharmaceuticals (ASX:RCE) completes cohort dosing in UTI rapid infusion trial
Recce Pharmaceuticals (ASX:RCE) paves its way to commercialisation with breakthrough antibiotic, R327 Posted on September 20, 2023September 25, 2024 by recce_com Recce Pharmaceuticals (ASX:RCE) paves its way to commercialisation with breakthrough antibiotic, R327
